Latest News

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form

May 10, 2021

The Company Announces Submission of Phase IIa Clinical Trial Application to the TFDA for Investigational New Drug AD17002-SC in Patients with Mild COVID-19.

Updates

May 10, 2021

【工商時報】昱厚鼻噴新冠藥AD17002-SC 申請台灣TFDA二期臨床

Press

May 10, 2021

【經濟日報】昱厚鼻噴新冠藥物已向食藥署申請二期a人體臨床試驗

Press

April 30, 2021

【經濟日報C5】昱厚鼻噴藥搶抗疫商機

Press

April 28, 2021

【經濟日報C6】昱厚新藥申請二期臨床

Press